• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Valproic acid is protective in cellular and worm models of oculopharyngeal muscular dystrophy.丙戊酸在眼咽型肌营养不良的细胞和线虫模型中具有保护作用。
Neurology. 2018 Aug 7;91(6):e551-e561. doi: 10.1212/WNL.0000000000005942. Epub 2018 Jul 13.
2
Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.新型眼咽型肌营养不良症(OPMD)小鼠模型揭示了早期线粒体缺陷,并表明聚腺苷酸结合蛋白核1(PABPN1)的缺失可能导致病变。
Hum Mol Genet. 2017 Sep 1;26(17):3235-3252. doi: 10.1093/hmg/ddx206.
3
Functional impact of an oculopharyngeal muscular dystrophy mutation in PABPN1.聚腺苷酸结合蛋白核 1(PABPN1)中眼咽型肌营养不良突变的功能影响
J Physiol. 2017 Jul 1;595(13):4167-4187. doi: 10.1113/JP273948. Epub 2017 Apr 25.
4
Mitochondrial localization of PABPN1 in oculopharyngeal muscular dystrophy.眼咽型肌营养不良症中 PABPN1 的线粒体定位。
Lab Invest. 2019 Nov;99(11):1728-1740. doi: 10.1038/s41374-019-0243-8. Epub 2019 Mar 20.
5
A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1.眼咽型肌营养不良的果蝇模型揭示了聚腺苷酸结合蛋白核 1 的内在毒性。
EMBO J. 2006 May 17;25(10):2253-62. doi: 10.1038/sj.emboj.7601117. Epub 2006 Apr 27.
6
Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.大样本患者队列和眼咽型肌营养不良症人异种移植模型中 PABPN1 核内包涵体的评估。
Acta Neuropathol. 2022 Dec;144(6):1157-1170. doi: 10.1007/s00401-022-02503-7. Epub 2022 Oct 5.
7
Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy.核内滞留和细胞外耗竭的 PCOLCE 与眼咽型肌营养不良症的肌肉退化有关。
BMC Neurol. 2013 Jul 1;13:70. doi: 10.1186/1471-2377-13-70.
8
Activation of the ubiquitin-proteasome system contributes to oculopharyngeal muscular dystrophy through muscle atrophy.泛素-蛋白酶体系统的激活通过肌肉萎缩导致进行性眼咽型肌营养不良。
PLoS Genet. 2022 Jan 13;18(1):e1010015. doi: 10.1371/journal.pgen.1010015. eCollection 2022 Jan.
9
Over-expression of BCL2 rescues muscle weakness in a mouse model of oculopharyngeal muscular dystrophy.BCL2 的过表达可挽救眼咽型肌营养不良症小鼠模型的肌肉无力。
Hum Mol Genet. 2011 Mar 15;20(6):1154-63. doi: 10.1093/hmg/ddq559. Epub 2011 Jan 3.
10
Lithium chloride attenuates cell death in oculopharyngeal muscular dystrophy by perturbing Wnt/β-catenin pathway.氯化锂通过扰乱 Wnt/β-连环蛋白通路来减轻口咽型肌营养不良症中的细胞死亡。
Cell Death Dis. 2013 Oct 3;4(10):e821. doi: 10.1038/cddis.2013.342.

引用本文的文献

1
Recent Progress in Oculopharyngeal Muscular Dystrophy.眼咽型肌营养不良症的最新进展
J Clin Med. 2021 Mar 29;10(7):1375. doi: 10.3390/jcm10071375.
2
Chromatin-modifying drugs and metabolites in cell fate control.染色质修饰药物及其代谢产物在细胞命运调控中的作用。
Cell Prolif. 2020 Nov;53(11):e12898. doi: 10.1111/cpr.12898. Epub 2020 Sep 26.
3
RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and Replacement.利用眼咽型肌营养不良转录本敲低和替代的基于RNA的疗法。
Mol Ther Nucleic Acids. 2019 Apr 15;15:12-25. doi: 10.1016/j.omtn.2019.02.003. Epub 2019 Feb 15.

本文引用的文献

1
Lithium chloride attenuates cell death in oculopharyngeal muscular dystrophy by perturbing Wnt/β-catenin pathway.氯化锂通过扰乱 Wnt/β-连环蛋白通路来减轻口咽型肌营养不良症中的细胞死亡。
Cell Death Dis. 2013 Oct 3;4(10):e821. doi: 10.1038/cddis.2013.342.
2
Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical study.自体成肌细胞移植治疗眼咽型肌营养不良症:一项 I/IIa 期临床研究。
Mol Ther. 2014 Jan;22(1):219-25. doi: 10.1038/mt.2013.155. Epub 2013 Jul 8.
3
Histone deacetylase inhibition suppresses myogenin-dependent atrogene activation in spinal muscular atrophy mice.组蛋白去乙酰化酶抑制可抑制脊髓性肌萎缩症小鼠中依赖肌生成素的萎缩基因激活。
Hum Mol Genet. 2012 Oct 15;21(20):4448-59. doi: 10.1093/hmg/dds286. Epub 2012 Jul 13.
4
Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres.眼咽型肌营养不良症小鼠模型的分子和表型特征分析显示,严重的肌肉萎缩仅限于快速糖酵解纤维。
Hum Mol Genet. 2010 Jun 1;19(11):2191-207. doi: 10.1093/hmg/ddq098. Epub 2010 Mar 5.
5
Valproic acid activates the PI3K/Akt/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy.丙戊酸激活肌肉中的PI3K/Akt/mTOR信号通路,并改善杜氏肌营养不良小鼠模型的病理状况。
Am J Pathol. 2009 Mar;174(3):999-1008. doi: 10.2353/ajpath.2009.080537. Epub 2009 Jan 29.
6
Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1.沉默调节蛋白抑制可保护免受聚丙氨酸型肌营养不良蛋白PABPN1的影响。
Hum Mol Genet. 2008 Jul 15;17(14):2108-17. doi: 10.1093/hmg/ddn109. Epub 2008 Apr 7.
7
Maintenance of C. elegans.秀丽隐杆线虫的饲养
WormBook. 2006 Feb 11:1-11. doi: 10.1895/wormbook.1.101.1.
8
Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.可溶性扩展型PABPN1促进眼咽型肌营养不良中的细胞死亡。
Neurobiol Dis. 2007 Jun;26(3):546-57. doi: 10.1016/j.nbd.2007.02.004. Epub 2007 Feb 15.
9
An automated tracking system for Caenorhabditis elegans locomotor behavior and circadian studies application.一种用于秀丽隐杆线虫运动行为和昼夜节律研究应用的自动跟踪系统。
J Neurosci Methods. 2007 Apr 15;161(2):273-80. doi: 10.1016/j.jneumeth.2006.11.015. Epub 2007 Jan 4.
10
Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies.眼咽型肌营养不良症:分子致病机制及治疗策略认识的最新进展
Biochim Biophys Acta. 2007 Feb;1772(2):173-85. doi: 10.1016/j.bbadis.2006.10.003. Epub 2006 Oct 11.

丙戊酸在眼咽型肌营养不良的细胞和线虫模型中具有保护作用。

Valproic acid is protective in cellular and worm models of oculopharyngeal muscular dystrophy.

机构信息

From the Montreal Neurological Institute and Hospital (A.A.-B., P.D., G.R.), Ingram School of Nursing, Faculty of Medicine (S.R.), and Department of Neurology and Neurosurgery (G.R.), McGill University, Montreal; CHUM Research Center (A.P.), Montreal; Department of Neuroscience (A.P.), and Ophthalmology Research Hôpital Maisonneuve Rosemont, Laboratoire de Isabelle Brunette (J.L.), University of Montreal; Neuromuscular Group (B.B.), Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada; and Brain C-lab (C.N.), Institute of Biology Paris-Seine, CNRS UMR 8256 Biology of Adaptation & Aging, University Pierre and Marie Curie, Paris, France.

出版信息

Neurology. 2018 Aug 7;91(6):e551-e561. doi: 10.1212/WNL.0000000000005942. Epub 2018 Jul 13.

DOI:10.1212/WNL.0000000000005942
PMID:30006409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6105050/
Abstract

OBJECTIVE

To explore valproic acid (VPA) as a potentially beneficial drug in cellular and worm models of oculopharyngeal muscular dystrophy (OPMD).

METHODS

Using a combination of live cell imaging and biochemical measures, we evaluated the potential protective effect of VPA in a stable C2C12 muscle cell model of OPMD, in lymphoblastoid cell lines derived from patients with OPMD and in a transgenic OPMD model expressing human mutant PABPN1.

RESULTS

We demonstrated that VPA protects against the toxicity of mutant PABPN1. Of note, we found that VPA confers its long-term protective effects on C2C12 cell survival, proliferation, and differentiation by increasing the acetylated level of histones. Furthermore, VPA enhances the level of histone acetylation in lymphoblastoid cell lines derived from patients with OPMD. Moreover, treatment of nematodes with moderate concentrations of VPA significantly improved the motility of the Alanines worms.

CONCLUSIONS

Our results suggest that VPA helps to counteract OPMD-related phenotypes in the cellular and disease models.

摘要

目的

探讨丙戊酸(VPA)在眼咽型肌营养不良症(OPMD)的细胞和线虫模型中作为一种潜在有益药物的作用。

方法

我们采用活细胞成像和生化测定相结合的方法,在稳定的 C2C12 肌营养不良症细胞模型、来自 OPMD 患者的淋巴母细胞系和表达人突变 PABPN1 的转基因 OPMD 模型中,评估了 VPA 的潜在保护作用。

结果

我们证明 VPA 可对抗突变 PABPN1 的毒性。值得注意的是,我们发现 VPA 通过增加组蛋白的乙酰化水平,对 C2C12 细胞的存活、增殖和分化发挥长期的保护作用。此外,VPA 可提高源自 OPMD 患者的淋巴母细胞系中的组蛋白乙酰化水平。此外,用中等浓度的 VPA 处理线虫可显著改善 Alanines 线虫的运动能力。

结论

我们的研究结果表明,VPA 有助于在细胞和疾病模型中对抗 OPMD 相关表型。